Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,862,222
-
Total 13F shares
-
18,997,897
-
Share change
-
+5,072,874
-
Total reported value
-
$240,166,135
-
Price per share
-
$12.63
-
Number of holders
-
30
-
Value change
-
+$64,576,294
-
Number of buys
-
22
-
Number of sells
-
7
Institutional Holders of Benitec Biopharma Inc. - Common Stock (BNTC) as of Q4 2024
As of 31 Dec 2024,
Benitec Biopharma Inc. - Common Stock (BNTC) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,997,897 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Nantahala Capital Management, LLC, VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, INFINITUM ASSET MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock, Inc..
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.